Jeffrey Poulton V.
EVP, Chief Financial Officer at Alnylam Pharmaceuticals. Based in Cambridge, Massachusetts.
- Rank
- 9374th of 14,452
- Companies held
- 1
- Largest holding
- ALNY, 100.0% of total
- Latest SEC filing
- Mar 4, 2026
What the $9.1M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Alnylam Pharmaceuticals ALNY Common Stock | Directly | 61,805 | $147.82 | $9.1M | 99.9% | Form 4, Mar 4, 2026 |
| Alnylam Pharmaceuticals ALNY Common Stock | Through Managed Account | 57 | $147.82 | $8K | 0.1% | Form 4, Mar 4, 2026 |
Share counts are the amounts Jeffrey Poulton V. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Sold | ALNY | 114 | $319.03 | $36K | View |
| Mar 4, 2026 | Sold | ALNY | 109 | $320.01 | $35K | View |
| Mar 4, 2026 | Sold | ALNY | 223 | $325.67 | $73K | View |
| Mar 4, 2026 | Sold | ALNY | 818 | $323.84 | $265K | View |
| Mar 4, 2026 | Sold | ALNY | 291 | $324.88 | $95K | View |
| Mar 4, 2026 | Sold | ALNY | 230 | $320.81 | $74K | View |
| Mar 4, 2026 | Sold | ALNY | 309 | $321.82 | $99K | View |
| Mar 4, 2026 | Sold | ALNY | 374 | $323.01 | $121K | View |
| Mar 2, 2026 | Sold | ALNY | 138 | $328.71 | $45K | View |
| Mar 2, 2026 | Sold | ALNY | 234 | $329.71 | $77K | View |
| Mar 2, 2026 | Sold | ALNY | 112 | $330.85 | $37K | View |
| Mar 2, 2026 | Sold | ALNY | 129 | $331.93 | $43K | View |
| Mar 2, 2026 | Sold | ALNY | 53 | $332.64 | $18K | View |
| Mar 2, 2026 | Sold | ALNY | 541 | $326.81 | $177K | View |
| Mar 2, 2026 | Sold | ALNY | 65 | $323.62 | $21K | View |
| Mar 2, 2026 | Sold | ALNY | 124 | $324.65 | $40K | View |
| Mar 2, 2026 | Sold | ALNY | 356 | $325.63 | $116K | View |
| Mar 2, 2026 | Sold | ALNY | 454 | $327.67 | $149K | View |
| Feb 13, 2026 | Sold | ALNY | 2,242 | $310.08 | $695K | View |
| Jan 12, 2026 | Sold | ALNY | 72 | $353.95 | $25K | View |
| Jan 12, 2026 | Sold | ALNY | 78 | $355.16 | $28K | View |
| Jan 12, 2026 | Sold | ALNY | 76 | $356.09 | $27K | View |
| Jan 12, 2026 | Sold | ALNY | 176 | $357.17 | $63K | View |
| Jan 12, 2026 | Sold | ALNY | 226 | $358.18 | $81K | View |
| Jan 12, 2026 | Sold | ALNY | 156 | $359.14 | $56K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 9371 | Lindsay A. Rosenwald Md PRESIDENT, CEO & CHAIRMAN, Fortress Biotech. Bay Harbor Islands, FL | $9.1M |
| 9372 | Jonathan S. Mothner See remarks, Synchrony Financial. Stamford, CT | $9.1M |
| 9373 | Adalio T. Sanchez Director, ACI Worldwide. Elkhorn, NE | $9.1M |
| 9374 | Jeffrey Poulton V. EVP, Chief Financial Officer, Alnylam Pharmaceuticals. Cambridge, MA | $9.1M |
| 9375 | Judd M. O.'Connor Chief Commercial and Operation, Vylor. Wilmington, DE | $9.1M |
| 9376 | Wright Michael G. 10% owner, Conexeu Sciences | $9.1M |
| 9377 | Stephen R. Springer Director, Atmos Energy. Dallas, TX | $9.1M |
Other Alnylam Pharmaceuticals insiders
All ALNY insiders- Phillip A. Sharp$39.5MDirector. #2946 overall
- John Maraganore$34.1MChief Executive Officer. #1983 overall
- Yvonne Greenstreet$12.6MChief Executive Officer. #7178 overall
- Tolga Tanguler$5.1MEVP, Chief Commercial Officer. #14320 overall
- David E. I. Pyott$4.9MDirector. #9651 overall
- Akshay Vaishnaw$3.4MPresident. #3321 overall
Questions
How much stock does Jeffrey Poulton V. own?
Jeffrey Poulton V. holds $9,144,441 in listed stock based on SEC filings and current prices, mostly Alnylam Pharmaceuticals (ALNY). That ranks 9374th on the Stock Rich List.
Is this Jeffrey Poulton V.'s net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Jeffrey Poulton V. last buy or sell stock?
The most recent open-market trade on file is a sale of 114 ALNY shares on Mar 4, 2026 at $319.03.